While binding of vector particles to these cells is highly likely, and may in the case of CD19-positive B cell lymphomas additionally be supported by vector particle-incorporated CD19-CAR (21, 39) binding is not sufficient for successful transduction. The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.